陽普醫療(300030.SZ)三日累跌20.19%:口罩等防疫產品銷售情況存不確定性
格隆匯3月19日丨陽普醫療(300030.SZ)三日累計跌幅達20.19%。公司表示,其主營業務是醫學實驗室診斷和醫療信息化業務。此次新冠疫情發生之前,口罩產品不是公司的主營業務產品,不構成公司的主營業務收入。自疫情發生以來,市場對公司口罩等疫情防控產品的需求激增,該類防疫產品對公司的銷售貢獻增加。
鑑於目前國外嚴重的疫情現狀,公司結合自身情況和市場需求增加了部分口罩產品的出口業務。由於疫情發展的不確定性以及市場競爭程度加劇,公司口罩等防疫產品的銷售情況存在不確定性,請投資者理性投資,注意投資風險。
公司研發的新冠病毒檢測試劑盒適用於杭州子公司康代思鋭生物科技公司自主研發的Q-velox平台,該檢測系統獨立、封閉、全自動、體積小,能夠快速為基層醫療機構提供標準化的檢測和診斷能力。受疫情影響,杭州地區相關企業復工延遲,此外,近期醫療器械應急註冊申請程序發生變化,導致試劑盒註冊進展存在不確定性。
目前,新冠病毒的檢測試劑盒已經完成設計及內部驗證,正在進行註冊證申報的準備工作,請投資者注意投資風險並留意後續公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.